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Abstract
In previous mass spectrometry and co-immune precipitation studies, we identified TRIM28 (TIF-1β, KAP-1) as a cofactor that specifically co-purified with an NR2C1/NR2C2 (TR2/TR4) orphan nuclear receptor heterodimer that previous studies had implicated as an embryonic/fetal β-type globin gene repressor. TRIM28 has been characterized as a transcriptional co-repressor that can associate with many different transcription factors and can play functional roles in multiple tissues and cell types. Here we tested the contribution of TRIM28 to globin gene regulation and erythropoiesis using a conditional loss of function in vivo model. We discovered that Trim28 genetic loss in the adult mouse leads to defective immature erythropoiesis in the bone marrow and consequently to anemia. We further found that TRIM28 controls erythropoiesis in a cellautonomous manner by inducibly deleting Trim28 exclusively in hematopoietic cells. During erythroid differentiation, initiation of globin gene transcription occurs at the erythroblast stages. The major form of hemoglobin, the essential vertebrate oxygen transporter, in the human fetal liver is HbF (α2γ2) and in the adult bone marrow is HbA (α2β2). Robust induction of HbF in individuals bearing deleterious mutations in the adult β-globin gene (e.g. in sickle cell anemia and β-thalassemia) ameliorates disease morbidity. 3, 4 To elucidate the molecular mechanism(s) that regulate fetal γ-globin gene repression in adult mammals, we previously reported the isolation and detailed characterization of the direct repeat erythroid-definitive (DRED) complex as a candidate repressor of both the embryonic and fetal β-type globin genes 5 and identified the DNAbinding orphan nuclear receptors NR2C1 (originally called TR2) and NR2C2 (aka TR4)
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From 5 as the DNA-binding subunits of the repressor. 6, 7 We subsequently described a number of NR2C1/2-binding proteins that were hypothesized to function as possible corepressors through epigenetic modifying activities, including LSD1, DNMT1 and TRIM28.
8 TRIM28 (aka KAP1, TIF1β) contains an N-terminal ring finger, two B-box zinc fingers, and a coiled-coil (RBCC) protein interaction domain as well as a C-terminal plant homeodomain/bromodomain (PB) transcriptional repressive sequence. 9,10 TRIM28 recruits heterochromatin protein 1 (HP1) through the central HP1-binding domain 11, 12 and recruits the histone H3K9 methyltransferase SETDB1 through the PB domain.
13
The ubiquitously expressed TRIM28 protein functions as a universal co-repressor for Krüppel-associated box (KRAB) domain-containing zinc finger transcription factors by binding via its RBCC domain.
9,10
Genetically modified mice in which the Trim28 gene was inactivated die between embryonic days 5.5 and 8.8. 14 TRIM28 function, among others, is required for the silencing of endogenous retroviruses in ES cells 15, 16 , for the pluripotency of ES cells 17, 18 , for proper DNA methylation in ES cells as well as for eliciting a timely transition from oocyte to embryo. 19, 20 TRIM28 mediates epigenetic repression in the forebrain and controls response to behavioral stress. 21 In hematopoietic cells, TRIM28 has been shown to control the development and functions of B 22 and T lymphoid cells [23] [24] [25] .
Although TRIM28 plays roles in multiple hematopoietic cells, its possible function(s) in myeloerythroid lineage cell development are unknown.
Since the TRIM28 protein was repeatedly recovered in immune complexes containing NR2C1/2 8 and is generally regarded as a co-repressor, we hypothesized that Quantitative PCR analysis of genomic DNA Flow sorted cells were lysed in Proteinase K plus SDS buffer followed by phenolchloroform extraction and isopropanol precipitation of genomic DNA. A Trim28 floxed allele-specific primer set was used to quantify gene deletion by quantitative PCR with SYBR Green dye on an ABI Prism 7000 (Applied Biosystems). Primers used were 5'-GGTGGCGGCCGCTCTAGTAT-3' and 5'-GCGGCCGCAGATCTCTATCTACT-3'. Total DNA content for normalization was analyzed using β-actin as the control.
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Quantification of Sry genomic DNA by quantitative PCR was performed as described previously.
Quantitative RT-PCR analyses
Total RNA was isolated from sorted cells using QIAGEN RNeasy Micro or Mini Kits with DNase treatment. Quantitative RT-PCR (qRT-PCR) was performed as described previously.
28 Expression levels were normalized to internal β-actin abundance. Primers used for the SYBR green assay were taken from the following citations: β-actin
32
, εY-globin, βH1-globin, adult β-globin
8
. The adult β-globin primer set co-amplifies both β major and β minor .
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RNA-Seq analysis
Total RNA was isolated from sorted immature erythrocytes using QIAGEN RNeasy Mini Kit with DNase treatment. Intact total RNA showing RNA integrity number of "10" (highest) on an Agilent Bioanalyzer was further processed using NuGEN Encore Complete RNA-Seq Library Systems at the University of Michigan Sequencing Core facility. The library was sequenced (50-50 bp paired-end) on an Illumina HiSeq2000.
Raw reads were mapped to the mm10 mouse genome sequence using TopHat and further analyzed with Cuffdiff and CummeRbund. 33 A default false discovery rate (FDR) of 0.05 was used for the statistical significance analysis in Cuffdiff. The data are deposited as GEO: GSE49843.
Statistical analysis
Statistical significance was determined using the Student's t test. Data were considered statistically significant when p < 0.05. We hypothesized that TRIM28 might normally contribute to repression of the embryonic and/or fetal globin genes and therefore that the mouse εY-and/or βH1-globin genes (the structural homologues of human embryonic ε− and fetal γ-globin genes, respectively) would be de-repressed in the absence of TRIM28. To test this hypothesis, we analyzed the expression of the β-type globin genes in the immature erythroid cell population by qRT-PCR. The level of εY-globin mRNA was unchanged. Although the level of βH1-globin mRNA increased slightly (not in a statistically significant manner), more than half of the animals analyzed had normal levels of these mRNAs ( Figure 1D ).
A mild decrease in adult β-globin mRNA was observed (but again, not statistically different and 1E, see below). In the peripheral blood of the TMC mutants, the RBC number as well as the HGB and HCT parameters significantly dropped, while the MCV was unchanged ( Figure 1H ). This normocytic anemic phenotype is often observed in diseases displaying defects in bone marrow erythropoiesis. 
Sca1
+ cKit hi ) and GMP populations were unaffected in the TMC mutant mice (Figures 2A and 2B ). In accord with the observation that GMP develop normally, the number of myeloid cells expressing Mac1 in the bone marrow was unaltered in the TMC mutant ( Figure 2C ). The number of monocytes and neutrophils in the peripheral blood of the TMC mutant animals at two or four weeks post poly(I:C) administration was not statistically altered when compared to control mice. The number of eosinophils was normal at two weeks and reduced by 28% at four weeks.
The number of basophils was transiently reduced to 35% of controls after two weeks, but recovered to normal levels by four weeks (data not shown). Thus, the number of myeloid lineage cells in the peripheral blood was essentially normal for monocytes and neutrophils.
We also observed a significant increase in the number of cKit hi Lin + cells ( Figure S4 ).
TRIM28 is cell-autonomously required for immature erythropoiesis.
To test whether or not TRIM28 was intrinsically required for erythroid differentiation, As expected (because of differentiation from the co-injected CD45.1 donor cells), two weeks after completion of poly(I:C) treatment no anemic phenotype was observed in the peripheral blood (data not shown) or bone marrow ( Figure 4C ) of the reconstituted animals, in contrast to the TMC mutants ( Figures 1E-H ). These data demonstrate that deficient immature erythropoiesis due to the loss of TRIM28 is not a secondary response to systemic anemia or to reduction in the number of erythroid lineage cells in the bone marrow, and that TRIM28 controls immature erythropoiesis in hematopoietic cell-autonomous fashion.
Loss of TRIM28 alters erythroid lineage gene expression.
To examine expression of the globin genes in greater detail and to address possible mechanisms that might be responsible for the observed defect in erythropoiesis in the TRIM28 mutant, we analyzed two immature erythroid populations in the TMC mouse (the δ and Δ cells shown in Figure 3F ) two weeks after poly(I:C) treatment by RNA-Seq. Figure S5 ) and RNA-Seq ( Figure S6 ) revealed an almost complete absence of TRIM28 mRNA coding sequence.
First, and in contrast to our original expectations, in both the δ and Δ cells the level of εY-, βH1-and βH2-globin mRNA was unchanged compared to control mice ( Figure 5 ).
Instead, we consistently observed an approximately 50% (but not statistically meaningful) reduction in adult β major , β minor and α-globin mRNAs in the Δ cells, but not in
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From the δ cells ( Figure 5 ). The level of α-and β-type globin mRNA was also analyzed and confirmed by qRT-PCR ( Figure S5 ). In contrast to RNA-Seq, βH1-globin mRNA was approximately two-fold (ranging from 1-3 fold) increased in both Δ and δ cells in the qRT-PCR assay. While one might have anticipated that only the most completely deleted animals would express higher levels of βH1-globin mRNA, we detected no such inverse correlation of TRIM28 mRNA and the β-type globin mRNAs in the either δ or Δ cells (data not shown). The data obtained from RNA-Seq and qRT-PCR indicates that the contribution of TRIM28 to embryonic/fetal globin gene silencing in adult erythroblasts is very modest, if any. These data also underscore our previous conclusion that TRIM28 is dispensable for embryonic and fetal β-type globin gene repression in adult definitive erythropoiesis.
Next, we examined the expression of factors that might be responsible for repressing embryonic/fetal-globin genes 3 by RNA-Seq ( Figure 5 ) and qRT-PCR ( Figure   S5 ). The expression profiles suggested that reduced levels of SOX6, KLF1 and NR2C2 might be compensated by increased BCL11A to maintain embryonic/fetal-globin repression in the adult TMC mutant mouse. KDMA1A/LSD1 and DNMT1 levels were unchanged.
To delve into the molecular mechanisms that might cause deficient immature erythropoiesis in the TMC mutant, erythroid-related factors were evaluated from the RNA-Seq data ( Figure 5 ) and by qRT-PCR ( Figure S5 ). We found that many erythroidaffiliated transcription factors (KLF2, ETS1, FOXO3, KLF13 and SOX6) were affected in a statistically significant manner. The analysis also revealed that there was a reduction in most of the enzymes required for heme biosynthesis (ALAS2, ALAD, HMBS, UROD FECH) . One difference between Δ and δ immature erythrocytes is cell surface TER119 expression, which is a molecule that associates with cell-surface glycophorin A (GYPA). 36 The fact that there was a significant reduction of GYPA mRNA only in the Δ cells ( Figure 5 ) suggests that the mutation should also have led to defective formation of the TER119-glycophorin A complex. Intriguingly, we found that many of genes that are often used as internal standards showed unstable expression profiles in the TMC mutant cells ( Figure S7 ). These data demonstrate that TRIM28 activates multiple transcription factors and heme biosynthetic enzymes in immature erythroid cells. Figure 6C) . Thus these data demonstrate that TRIM28 represses apoptosis in immature erythroid cells.
These data demonstrate that TMC mutant mice somehow generate two distinct types of immature erythroid cells, Δ and δ (Figures 3, 6D and S4) . The majority of cells of both populations bear homozygous deletions of the Trim28 gene ( Figure 1C Figures 1B and 1E ).
These data indicate that TRIM28 is not required for the expression of TER119 for approximately half of the immature erythroid cells. These data taken together suggest that TRIM28 controls immature stages of erythropoiesis by regulating multiple erythroid transcription factors, multiple heme biosynthesis enzymes and apoptosis.
Discussion
Erythroid-specific expression of the mammalian globin genes is controlled by multiple tissue-specific and -restricted positive and negative transcriptional regulators.
The nuclear receptors NR2C1 and NR2C2 were originally identified in erythroid cells as direct transcriptional repressors of the embryonic and fetal β-type globin genes. [5] [6] [7] Multiple transcriptional co-factors, including TRIM28, was among numerous other NR2C1/2-associated proteins identified later. 8 Here we tested the requirement for TRIM28 on embryonic/fetal globin gene repression by inducibly ablating Trim28 in adult mice employing the poly(I:C)-inducible Mx1Cre transgene, referred to as TMC mutants.
Somewhat surprisingly, the expression of εY-and βH1-globin mRNAs was not altered after induced genetic loss of TRIM28; however, efficiently Trim28-deleted mice suffered from severe normocytic anemia. Subsequently, defects in erythropoiesis in the bone marrow were observed at multiple erythroblast differentiation stages in the Trim28 mutants. CMP and MEP progenitors, but not HSC/MPP or GMP progenitors, abnormally accumulated in the TMC mutant animals. In competitive adoptive transfer experiments, a similar reduction of erythroblasts was observed when the mutants were assayed shortly after poly(I:C) administration/Trim28 ablation. These results in summary demonstrated that TRIM28 is not required for the repression of embryonic/fetal globin genes during adult (definitive) erythropoiesis, but is required for the differentiation of erythroblasts from CMP and/or MEP progenitors in a cell-autonomous fashion.
In contrast to the erythroid defects, development of myeloid cells appeared to be quite normal in both the bone marrow (Mac1 + ) and peripheral blood (monocytes and neutrophils). Additionally, we recorded a statistically significant reduction in the number decreased (KLF1, SOX6 and NR2C2) and increased (BCL11A) factors seems to offset one another to maintain εY-and βH1-globin gene repression in the TMC mutant.
Although these data demonstrate that TRIM28 is not required for the maintenance of embryonic/fetal β-type globin gene repression, it is nonetheless possible that TRIM28 may contribute to the initiation of their silencing.
RNA-Seq followed by Cuffdiif statistical analyses revealed 860 and 1,352 upregulated genes, while 1,516 and 1,614 down-regulated genes in the δ and Δ immature erythroid cells, respectively. This result was somewhat unexpected since TRIM28 has been shown to recruit HP1 and SETDB1, both of which function in transcriptional repression, and was in general previously recognized solely as a co-repressor. 
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